Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

to connected objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: British Journal of Cancer, 104, 10, S. 1641-1648

Event
Veröffentlichung
(where)
Augsburg
(who)
Universität Augsburg
(when)
2011
Event
Veröffentlichung
(where)
Edinburgh
(who)
Springer Science and Business Media LLC
(when)
2011
Creator
Bauernhofer, T.
Pichler, Martin
Wieckowski, E.
Stanson, J.
Aigelsreiter, A.
Griesbacher, A.
Groselj-Strele, A.
Linecker, A.
Samonigg, H.
Langner, C.
Whiteside, T. L.

DOI
10.1038/bjc.2011.131
URN
urn:nbn:de:bvb:384-opus4-1057685
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:50 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Bauernhofer, T.
  • Pichler, Martin
  • Wieckowski, E.
  • Stanson, J.
  • Aigelsreiter, A.
  • Griesbacher, A.
  • Groselj-Strele, A.
  • Linecker, A.
  • Samonigg, H.
  • Langner, C.
  • Whiteside, T. L.
  • Universität Augsburg
  • Springer Science and Business Media LLC

Time of origin

  • 2011

Other Objects (12)

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma

Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma

Best of ASCO 2022: bladder cancer

Best of ASCO 2022: bladder cancer

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Inflammation, phagocytosis and cancer: another step in the CD47 act

Inflammation, phagocytosis and cancer: another step in the CD47 act

The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck

The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation

Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation

Related objects